Novolog Pharm-Up 1966 Ltd (NVLG) - Total Liabilities

Latest as of December 2025: ILA1.78 Billion ILA ≈ $4.77 Million USD

Based on the latest financial reports, Novolog Pharm-Up 1966 Ltd (NVLG) has total liabilities worth ILA1.78 Billion ILA (≈ $4.77 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Novolog Pharm-Up 1966 Ltd net asset momentum to track the company's year-over-year net asset growth rate.

Novolog Pharm-Up 1966 Ltd - Total Liabilities Trend (2014–2025)

This chart illustrates how Novolog Pharm-Up 1966 Ltd's total liabilities have evolved over time, based on quarterly financial data. See cash generation quality of Novolog Pharm-Up 1966 Ltd to measure how efficiently the company converts operating cash flow to free cash.

Novolog Pharm-Up 1966 Ltd Competitors by Total Liabilities

The table below lists competitors of Novolog Pharm-Up 1966 Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
NEOWIZ HOLDINGS Corporation KQ:042420	Korea	₩150.12 Billion
GREEN CROSS WellBeing Corporation KQ:234690	Korea	₩126.28 Billion
Surge Copper Corp V:SURG	Canada	CA$6.01 Million
PannErgy Nyrt. F:PPL	Germany	€15.22 Billion
PT Surya Pertiwi Tbk JK:SPTO	Indonesia	Rp1.03 Trillion
Gongin Precision Industrial Co Ltd TWO:3178	Taiwan	NT$1.52 Billion
Zeder Investments Ltd JSE:ZED	South Africa	ZAC34.00 Million
NOMAD Power Solutions, Inc. NASDAQ:NMAD	USA	$1.69 Million

Liability Composition Analysis (2014–2025)

This chart breaks down Novolog Pharm-Up 1966 Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Novolog Pharm-Up 1966 Ltd (NVLG) market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.91	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	4.98	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.83	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Novolog Pharm-Up 1966 Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Novolog Pharm-Up 1966 Ltd (2014–2025)

The table below shows the annual total liabilities of Novolog Pharm-Up 1966 Ltd from 2014 to 2025.

Year	Total Liabilities	Change
2025-12-31	ILA1.78 Billion ≈ $4.77 Million	-33.00%
2024-12-31	ILA2.65 Billion ≈ $7.12 Million	+10.97%
2023-12-31	ILA2.39 Billion ≈ $6.41 Million	+21.29%
2022-12-31	ILA1.97 Billion ≈ $5.29 Million	+6.15%
2021-12-31	ILA1.86 Billion ≈ $4.98 Million	-1.73%
2020-12-31	ILA1.89 Billion ≈ $5.07 Million	+0.23%
2019-12-31	ILA1.89 Billion ≈ $5.06 Million	+15.70%
2018-12-31	ILA1.63 Billion ≈ $4.37 Million	-5.22%
2017-12-31	ILA1.72 Billion ≈ $4.61 Million	+18.42%
2016-12-31	ILA1.45 Billion ≈ $3.89 Million	-5.48%
2015-12-31	ILA1.54 Billion ≈ $4.12 Million	+24.78%
2014-12-31	ILA1.23 Billion ≈ $3.30 Million	--

About Novolog Pharm-Up 1966 Ltd

TA:NVLG Israel Medical Distribution

Market Cap

$94.23 Million

ILA35.15 Billion ILA

Market Cap Rank

#19371 Global

#251 in Israel

Share Price

ILA68.80

Change (1 day)

-0.43%

52-Week Range

ILA66.80 - ILA153.00

All Time High

ILA337.91